Rossari Biotech
Chemicals · NSE
↑ 3.9% vs fair value
52W Low
₹375
+19.2% from low
52W High
₹766
-41.6% from high
Valuation Gauge
Current Price
₹447
Fair Value
₹465
Fair Value Analysis
₹465
Based on balance sheet strength analysis and earnings growth potential for Chemicals sector companies | CAUTION: ROCE declining (latest 18.9%) — returns on capital are falling; verify this isn't a value trap. | Growth capped at 12.6% (ROE 11.0%×1.15) — historical CAGR exceeds sustainable rate or COVID period unverifiable.
Balance Sheet Value
60% weight
Growth Valuation
40% weight
Price vs Market
Shareholding Pattern
Stock Health Score
Solid Fundamentals
Profitability
ROE of 11.0% is acceptable for Chemicals sector (benchmark: 15%)
Debt & Leverage
D/E ratio of 0.3x is well within the Chemicals sector norm of 0.8x — strong balance sheet
Valuation vs Peers
P/E of 17.2x trades at a 73% discount to Chemicals sector median (64x) — attractively valued
Cash Flow
Negative FCF of ₹-21 Cr — company is consuming more cash than it generates
Earnings Growth
5yr EPS CAGR of 11.8% is below the Chemicals sector average of 14.1%
Dividend
Dividend yield of 0.1% is symbolic — low but positive
Sentiment Trend — Last 30 Days
Historical Returns
Key Ratios & Growth
FCF Yield
-1.9%
Free cash flow / market cap
Revenue Growth (YoY)
+13.5%
Year-on-year revenue change
Profit Growth (YoY)
+3.1%
Year-on-year PAT change
Operating Cash Flow
₹137 Cr
TTM cash from operations
Key Financials
EPS (TTM)
₹24.9
P/E Ratio
17.2x
P/B Ratio
1.9x
ROE
11%
ROCE
14.9%
Debt / Equity
0.28x
Beta
0.33
Div Yield
0.1%
FCF (Cr)
₹-21 Cr
Revenue (Cr)
₹2,071 Cr
EPS Growth 5Y
11.8%
Mkt Cap (Cr)
₹2,371 Cr
52W High
₹766
52W Low
₹375
Book Value/Share
₹224.4
Financial History
| Period | Revenue | Op Profit | OPM% | PAT | EPS |
|---|---|---|---|---|---|
| TTM | ₹2.3K Cr | ₹278 Cr | 12.0% | ₹138 Cr | ₹24.87 |
| 2025-03-31 | ₹2.1K Cr | ₹265 Cr | 13.0% | ₹136 Cr | ₹24.63 |
| 2024-03-31 | ₹1.8K Cr | ₹250 Cr | 14.0% | ₹131 Cr | ₹23.66 |
| 2023-03-31 | ₹1.7K Cr | ₹223 Cr | 13.0% | ₹107 Cr | ₹19.45 |
| 2022-03-31 | ₹1.5K Cr | ₹184 Cr | 12.0% | ₹98 Cr | ₹17.74 |
| 2021-03-31 | ₹709 Cr | ₹124 Cr | 17.0% | ₹80 Cr | ₹15.45 |
| 2020-03-31 | ₹600 Cr | ₹105 Cr | 17.0% | ₹65 Cr | ₹12.86 |
| 2019-03-31 | ₹516 Cr | ₹78 Cr | 15.0% | ₹46 Cr | ₹103.82 |
Compounded Growth Rates
Sales Growth
Profit Growth
EPS Growth
Peer Comparison
Chemicals| Stock | Price | Fair Value | MoS% | P/E | ROE | Signal |
|---|---|---|---|---|---|---|
Madras Fertilizers Limited | ₹60 | ₹246.1 | +75.6% | 130.7 | 451.3% | UNDERVALUED |
ShreeOswal Seeds And Chemicals Limited | ₹10.8 | ₹41.2 | +73.8% | 26.9 | 11.8% | UNDERVALUED |
Kothari Petrochemicals Limited | ₹117.5 | ₹310.2 | +62.1% | 9 | 86.4% | UNDERVALUED |
Kothari Sugars And Chemicals Limited | ₹24.1 | ₹45.6 | +47.0% | 37.2 | 12.9% | UNDERVALUED |
Agro Phos India Limited | ₹31 | ₹54.2 | +42.8% | 11.2 | 13.9% | UNDERVALUED |
Aries Agro Limited | ₹358.4 | ₹620.4 | +42.2% | 10.3 | 9.9% | UNDERVALUED |
Epigral Limited | ₹905 | ₹1,514.2 | +40.2% | 11.3 | 14.8% | UNDERVALUED |
Deepak Fertilizers and Petrochemicals Corporation Limited | ₹982.5 | ₹1,402 | +29.9% | 14.3 | 13.5% | UNDERVALUED |
Institutional Activity
Bulk deals, block deals, short selling & delivery volume — NSE data
Insider Trading
Company Documents
Annual reports, concall transcripts & regulatory filings
Share this Stock
Download card · Share on WhatsApp
Share on WhatsApp, Twitter, or any group — each share brings new users to Veritas Quant
Analyst Note
Today
Rossari Biotech is fairly valued with ₹447 trading 8.2% below its fair value of ₹464.9, supported by medium-confidence valuation metrics. However, fundamental concerns temper enthusiasm: the company generated negative free cash flow of ₹21 Cr, earnings growth slowed to 3.3% year-on-year despite 13.4% revenue expansion, and ROCE is deteriorating. While sentiment remains stable and bullish over the last week, quality concerns including negative FCF and paper profits warrant caution. Best suited for value investors comfortable with near-term execution risks in the specialty chemicals space.
What is Dalal Street saying?
r/IndiaInvestments · r/Dalal_Street_Investments · r/IndianStockMarket
No Reddit mentions found yet for ROSSARI.
Telegram Channels
ET Markets · CNBC TV18 · Moneycontrol · Zee Business · NDTV Profit
No Telegram mentions found yet for ROSSARI.
StockTwits
What traders are saying right now
No StockTwits activity found for ROSSARI.
Search Interest
Google Trends · India · Last 90 days"Rossari Biotech"
Interest score (0 = low, 100 = peak)
90-day trend
Technical Pulse
Plain English — no jargon
Trading 28.7% below its 200-day average — stock has been in a steep downtrend.
RSI is 45 — neutral momentum, neither overbought nor oversold.
Below both 20-day and 50-day averages — no short-term recovery signal yet.
Fairly valued but technically weak. No strong reason to buy right now — wait for momentum to improve.
Rossari Biotech Ltd is Rated Sell - Markets Mojo
Rossari Biotech Subsidiary Unitop Chemicals Approves Sale of Mumbai Office Premises for Rs 10 Crores - scanx.trade
Rossari Biotech Submits Q4 FY26 Compliance Certificate for Share Dematerialisation - scanx.trade
Rossari Biotech Ltd Surges 7.83% to Day's High of Rs 435.1 — Outperforms Sector by 8.28 Percentage Points - Markets Mojo
Rossari Biotech Ltd Opens 5.06% Higher Amid Mixed Technical Signals - Markets Mojo
Rossari Biotech Ltd Surges 7.3% to Day's High of Rs 406.55 — Outperforms Sector by 1.09 Percentage Points - Markets Mojo
Rossari Biotech Shares Surge 7% as Unitop Chemicals Doubles Ethoxylation Capacity - tradebrains.in
Rossari Biotech Ltd Falls to 52-Week Low of Rs 380.35 as Sell-Off Deepens - Markets Mojo
Rossari Biotech Ltd Slides to All-Time Low Amid Prolonged Downtrend - Markets Mojo
Rossari Biotech Ltd Falls to 52-Week Low of Rs 395 as Sell-Off Deepens - Markets Mojo
Rossari Biotech Ltd Falls to 52-Week Low of Rs 395 as Sell-Off Deepens - Markets Mojo
Rossari Biotech Ltd Extends Losing Streak to Three Sessions, Touches All-Time Low - Markets Mojo
Rossari Biotech Ltd is Rated Sell - Markets Mojo
Rossari Biotech Ltd is Rated Sell - Markets Mojo
Rossari Biotech Ltd is Rated Sell - Markets Mojo
Rossari Biotech Ltd Extends Losing Streak to Two Sessions, Touches All-Time Low - Markets Mojo
Rossari Biotech Ltd Falls to 52-Week Low of Rs 414.15 as Sell-Off Deepens - Markets Mojo
Rossari Biotech Ltd Falls to 52-Week Low of Rs.418.3 Amid Continued Underperformance - Markets Mojo
Rossari Biotech Ltd Falls to 52-Week Low of Rs.428.1 Amid Continued Downtrend - Markets Mojo
Rossari Biotech Ltd Hits All-Time Low Amid Continued Market Underperformance - Markets Mojo